Insulin-like growth factor I (IGF-I) is a pivotal player in the multifaceted process of malignant disease, including lung cancer, and signaling through the IGF-I receptor (IGF-IR) stimulates mitogenesis, metabolism, and anti-apoptosis (1, 2). Here, IGF1R is linked to lung cancer.